ALK Inhibitor in Metastatic Colorectal Cancer With ALK Mutation.

ABSTRACT: This clinical trial aims to evaluate the efficacy, safety of ALK inhibitor in Metastatic Colorectal Cancer Patients with ALK mutation.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2293470 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR